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Background: A wide spectrum of neurological and neuromuscular human diseases have been associated 
with mitochondrial DNA (mtDNA) variations, causing defects of oxidative phosphorylation. These 
dysfunctions affect preferentially tissues with high energy demands and give arise to several degenerative 
disorders such as optic neuropathy, cerebellar ataxia, movement disorders, dementia, muscle weakness 
and deafness. The extremely heterogeneous clinical phenotype is due to the involved tissue, to specific 
mtDNA mutations and their heteroplasmic level, but also to nuclear DNA alterations, environmental and 
epigenetic factors. In this study we investigated a child affected by a complex neurological disease whose 
clinical features were suggestive of a mitochondrial involvement. Methods: mtDNA from proband, her 
healthy relatives (grandmother, mother and two sisters) and 80 controls were collected and studied by 
sequencing. The enzymatic activity of specific respiratory chain complex was tested on lymphocytes by 
spectrophotometric assay. Bioinformatic analysis was performed to predict the pathogenicity of the 
detected variants. Results: In all subjects we detected 11 known polymorphisms, whereas 1 novel 
heteroplasmic variant in complex I [ND5:12514G>A (E60K)] was present only in the proband and in her 
grandmother and absent in controls. The bioinformatics predicted the novel variant to be deleterious. 
Further, spectrophotometric assay of complex I activity was lower both in the proband and in her relatives 
than in the controls. Conclusions: We report a novel mtDNA variant detected in a patient affected by a 
complex neurological disease. The reduction of complex I respiratory chain activity associated to this 
variant suggests it could exert a pathogenic role in the disease. 
